This is a clone of the Texas Administrative Code (TAC) for educational purposes. It is not the official version and should not be used for legal purposes. Site created Wed, 21 May 2025 21:16:49 GMT

TITLE 28 - INSURANCE
PART 1 - TEXAS DEPARTMENT OF INSURANCE
CHAPTER 21 - TRADE PRACTICES
SUBCHAPTER H - UNFAIR DISCRIMINATION
SECTION/RULE §21.705 - Nondiscriminatory Testing for Human Immunodeficiency Virus
Chapter Review Date 06/08/2021

A proposed insured for life or health and accident insurance, or for coverage by a company licensed under Insurance Code Chapter 842, or with a licensed health maintenance organization may be required to be tested for the presence of the human immunodeficiency virus (HIV). Requiring such testing is not unfair discrimination provided:(1) the testing is required on a nondiscriminatory basis for all individuals in the same class; and(2) no proposed insured is denied coverage or rated a substandard risk on the basis of such testing unless:(A) an initial enzyme linked immunosorbent assay (ELISA) test is administered to the proposed insured, and it indicates the presence of HIV antibodies;(B) a second ELISA test is conducted and it indicates the presence of HIV antibodies; and(C) a Western Blot test is conducted and it confirms the results of the two ELISA tests.(3) the tests and testing procedures used have been approved by the United States Food and Drug Administration (FDA) and otherwise comply with applicable Texas and federal laws.

Source Note: The provisions of this §21.705 adopted to be effective February 1, 1988, 13 TexReg 346; amended to be effective January 8, 1997, 22 TexReg 53; amended to be effective November 7, 2021, 46 TexReg 7408.

View Official Rule